+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Solid Dosage Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Oral Solid Dosage Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Oral Solid Dosage Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 190 Pages
  • September 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5934471
Description Jump to:
The global oral solid dosage contract manufacturing market size is likely to be valued at US$ 36.4 Bn in 2025 and is estimated to reach US$ 60 Bn by 2032, growing at a CAGR of 7.40% during the forecast period 2025-2032. The market is witnessing strong demand due to increasing outsourcing by pharmaceutical and biopharmaceutical companies, rising demand for cost-effective drug production, and growing preference for oral solid dosage (OSD) forms due to their stability and patient compliance.

Market Insights

The oral solid dosage contract manufacturing market encompasses a wide range of drug production services, including tablets, capsules, softgels, powders, and other dosage forms. OSDs remain the most common and convenient drug delivery method, favored by patients and healthcare providers alike for their ease of use, longer shelf life, and cost efficiency. Contract manufacturers play a vital role in supporting pharmaceutical companies by offering development, manufacturing, and packaging services that reduce time-to-market and optimize operational costs. This outsourcing trend is further accelerated by increasing complexity of drug formulations and the growing pipeline of generics and nutraceuticals.

Market Growth Drivers

The growth of the oral solid dosage contract manufacturing market is being driven by several factors. Increasing demand for generics and cost-efficient drug production has fueled outsourcing to specialized CDMOs (Contract Development and Manufacturing Organizations). Rising prevalence of chronic diseases is expanding the demand for OSD formulations, particularly tablets and capsules. Additionally, pharmaceutical companies are increasingly outsourcing to gain access to advanced manufacturing technologies and regulatory expertise, reducing overall risks and costs. Growing nutraceutical demand and expansion of emerging markets also add to industry momentum.

Market Restraints

Despite strong growth potential, the market faces challenges. Stringent regulatory requirements in key regions such as the U.S. and Europe pose compliance challenges for contract manufacturers. High capital investment in advanced equipment and facilities also limits smaller players. Intellectual property concerns during outsourcing agreements remain a critical restraint. Moreover, competition from in-house manufacturing in large pharmaceutical companies, coupled with quality control issues in low-cost outsourcing destinations, can hinder growth prospects.

Market Opportunities

The oral solid dosage contract manufacturing market presents significant opportunities in the coming years. The rising shift toward controlled and modified release formulations opens avenues for specialized CDMOs. Emerging markets such as Asia-Pacific and Latin America provide immense potential due to increasing pharmaceutical investments and cost advantages. Additionally, the growing nutraceutical and wellness product market is boosting demand for OSD contract manufacturing. Strategic collaborations between pharmaceutical companies and contract manufacturers, along with adoption of advanced continuous manufacturing technologies, are expected to create further growth prospects.

Regional Outlook

  • North America: Dominates the market due to a strong pharmaceutical industry, advanced manufacturing capabilities, and strict regulatory frameworks that encourage outsourcing for efficiency.
  • Europe: Witnesses significant outsourcing trends driven by patent expirations, high R&D costs, and demand for generics. Germany and the UK lead in OSD outsourcing.
  • Asia Pacific: Expected to grow rapidly, led by India and China, which offer cost-effective production, skilled workforce, and strong government support for pharmaceutical manufacturing.
  • Latin America: Shows potential with increasing demand for affordable generics and rising healthcare access.
  • Middle East & Africa: Emerging market, supported by growing healthcare infrastructure and demand for cost-efficient medicines.

Leading Companies

Leading companies in the global oral solid dosage contract manufacturing market are focusing on partnerships, facility expansions, and advanced technology adoption to strengthen their positions.

Companies Covered in This Report:

  • Recipharm
  • Aenova Holding
  • Catalent
  • AbbVie
  • Patheon N.V. (Thermo Fisher Scientific)
  • NextPharma
  • Lonza Group AG
  • Merck KGaA
  • Aurobindo Pharma Limited
  • Siegfried AG
  • Piramal Pharma Solutions
  • Corden Pharma
  • HERMES PHARMA GmbH
  • Medipaams India Private Limited
  • Alpex Pharma
  • Abaris Healthcare Pvt Ltd
  • Ardena Holdings N.V.
  • Aphena Pharma Solutions
  • Actiza Pharmaceutical Private Limited
  • Sunwin Healthcare PVT. LTD
  • Kosher Pharmaceuticals
  • Boehringer Ingelheim BioXcellence
  • Others

Market Segmentation

By Dosage Form

  • Tablets
  • Capsules
  • Softgels
  • Powders
  • Granules
  • Gummies
  • Others

By Mechanism

  • Immediate Release
  • Delayed Release
  • Controlled Release

By Application

  • Drug Product Development
  • Fill & Finish Product Manufacturing
  • Packaging / Labelling
  • Others

By End User

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Emerging/Virtual Pharma Companies
  • Nutraceutical Companies

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Oral Solid Dosage Contract Manufacturing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
3.1. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Tablets
3.1.1.1.1. Conventional Release
3.1.1.1.2. Modified Release
3.1.1.1.3. Chewable Tablets
3.1.1.1.4. Effervescent Tablets
3.1.1.2. Capsules
3.1.1.2.1. Hard Gelatin Capsules
3.1.1.2.2. Soft Gelatin
3.1.1.3. Capsules/Softgels
3.1.1.4. Powders & Granules
3.1.1.5. Lozenges & Pastilles
3.1.1.6. Gummies
3.2. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Immediate Release
3.2.1.2. Delayed Release
3.2.1.3. Controlled Release
3.3. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Drug Product Development
3.3.1.2. Fill & Finish Product Manufacturing
3.3.1.3. Packaging /Labelling
3.3.1.4. Others
3.4. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Big Pharma/Biotech Companies
3.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
3.4.1.3. Emerging/virtual Pharma Companies
3.4.1.4. Nutraceutical Companies
3.5. Global Oral Solid Dosage Contract Manufacturing Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
4.1. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Tablets
4.1.1.1.1. Conventional Release
4.1.1.1.2. Modified Release
4.1.1.1.3. Chewable Tablets
4.1.1.1.4. Effervescent Tablets
4.1.1.2. Capsules
4.1.1.2.1. Hard Gelatin Capsules
4.1.1.2.2. Soft Gelatin
4.1.1.3. Capsules/Softgels
4.1.1.4. Powders & Granules
4.1.1.5. Lozenges & Pastilles
4.1.1.6. Gummies
4.2. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Immediate Release
4.2.1.2. Delayed Release
4.2.1.3. Controlled Release
4.3. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Drug Product Development
4.3.1.2. Fill & Finish Product Manufacturing
4.3.1.3. Packaging /Labelling
4.3.1.4. Others
4.4. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Big Pharma/Biotech Companies
4.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
4.4.1.3. Emerging/virtual Pharma Companies
4.4.1.4. Nutraceutical Companies
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
4.5.1.2. U.S. Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
4.5.1.3. U.S. Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
4.5.1.4. U.S. Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
4.5.1.5. Canada Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
4.5.1.6. Canada Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
4.5.1.7. Canada Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
4.5.1.8. Canada Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
5.1. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Tablets
5.1.1.1.1. Conventional Release
5.1.1.1.2. Modified Release
5.1.1.1.3. Chewable Tablets
5.1.1.1.4. Effervescent Tablets
5.1.1.2. Capsules
5.1.1.2.1. Hard Gelatin Capsules
5.1.1.2.2. Soft Gelatin
5.1.1.3. Capsules/Softgels
5.1.1.4. Powders & Granules
5.1.1.5. Lozenges & Pastilles
5.1.1.6. Gummies
5.2. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Immediate Release
5.2.1.2. Delayed Release
5.2.1.3. Controlled Release
5.3. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Drug Product Development
5.3.1.2. Fill & Finish Product Manufacturing
5.3.1.3. Packaging /Labelling
5.3.1.4. Others
5.4. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Big Pharma/Biotech Companies
5.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
5.4.1.3. Emerging/virtual Pharma Companies
5.4.1.4. Nutraceutical Companies
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.2. Germany Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.3. Germany Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.4. Germany Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.5. U.K. Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.6. U.K. Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.7. U.K. Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.8. U.K. Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.9. France Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.10. France Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.11. France Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.12. France Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.13. Italy Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.14. Italy Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.15. Italy Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.16. Italy Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.17. Turkey Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.18. Turkey Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.19. Turkey Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.20. Turkey Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.21. Russia Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.22. Russia Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.23. Russia Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.24. Russia Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.1.25. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
5.5.1.26. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
5.5.1.27. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
5.5.1.28. Rest of Europe Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
6.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Tablets
6.1.1.1.1. Conventional Release
6.1.1.1.2. Modified Release
6.1.1.1.3. Chewable Tablets
6.1.1.1.4. Effervescent Tablets
6.1.1.2. Capsules
6.1.1.2.1. Hard Gelatin Capsules
6.1.1.2.2. Soft Gelatin
6.1.1.3. Capsules/Softgels
6.1.1.4. Powders & Granules
6.1.1.5. Lozenges & Pastilles
6.1.1.6. Gummies
6.2. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Immediate Release
6.2.1.2. Delayed Release
6.2.1.3. Controlled Release
6.3. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Drug Product Development
6.3.1.2. Fill & Finish Product Manufacturing
6.3.1.3. Packaging /Labelling
6.3.1.4. Others
6.4. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Big Pharma/Biotech Companies
6.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
6.4.1.3. Emerging/virtual Pharma Companies
6.4.1.4. Nutraceutical Companies
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.2. China Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.3. China Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.4. China Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.1.5. Japan Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.6. Japan Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.7. Japan Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.8. Japan Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.1.9. South Korea Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.10. South Korea Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.11. South Korea Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.12. South Korea Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.1.13. India Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.14. India Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.15. India Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.16. India Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.1.17. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.18. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.19. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.20. Southeast Asia Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.1.21. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
6.5.1.22. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
6.5.1.23. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
6.5.1.24. Rest of Asia Pacific Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
7.1. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Tablets
7.1.1.1.1. Conventional Release
7.1.1.1.2. Modified Release
7.1.1.1.3. Chewable Tablets
7.1.1.1.4. Effervescent Tablets
7.1.1.2. Capsules
7.1.1.2.1. Hard Gelatin Capsules
7.1.1.2.2. Soft Gelatin
7.1.1.3. Capsules/Softgels
7.1.1.4. Powders & Granules
7.1.1.5. Lozenges & Pastilles
7.1.1.6. Gummies
7.2. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Immediate Release
7.2.1.2. Delayed Release
7.2.1.3. Controlled Release
7.3. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Drug Product Development
7.3.1.2. Fill & Finish Product Manufacturing
7.3.1.3. Packaging /Labelling
7.3.1.4. Others
7.4. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Big Pharma/Biotech Companies
7.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
7.4.1.3. Emerging/virtual Pharma Companies
7.4.1.4. Nutraceutical Companies
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
7.5.1.2. Brazil Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
7.5.1.3. Brazil Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
7.5.1.4. Brazil Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
7.5.1.5. Mexico Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
7.5.1.6. Mexico Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
7.5.1.7. Mexico Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
7.5.1.8. Mexico Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
7.5.1.9. Argentina Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
7.5.1.10. Argentina Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
7.5.1.11. Argentina Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
7.5.1.12. Argentina Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
7.5.1.13. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
7.5.1.14. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
7.5.1.15. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
7.5.1.16. Rest of Latin America Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, 2019-2032
8.1. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Tablets
8.1.1.1.1. Conventional Release
8.1.1.1.2. Modified Release
8.1.1.1.3. Chewable Tablets
8.1.1.1.4. Effervescent Tablets
8.1.1.2. Capsules
8.1.1.2.1. Hard Gelatin Capsules
8.1.1.2.2. Soft Gelatin
8.1.1.3. Capsules/Softgels
8.1.1.4. Powders & Granules
8.1.1.5. Lozenges & Pastilles
8.1.1.6. Gummies
8.2. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Mechanism, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Immediate Release
8.2.1.2. Delayed Release
8.2.1.3. Controlled Release
8.3. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Application Type, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Drug Product Development
8.3.1.2. Fill & Finish Product Manufacturing
8.3.1.3. Packaging /Labelling
8.3.1.4. Others
8.4. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Big Pharma/Biotech Companies
8.4.1.2. Smalls & Medium-size Pharma/Biotech Companies
8.4.1.3. Emerging/virtual Pharma Companies
8.4.1.4. Nutraceutical Companies
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
8.5.1.2. GCC Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
8.5.1.3. GCC Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
8.5.1.4. GCC Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
8.5.1.5. South Africa Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
8.5.1.6. South Africa Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
8.5.1.7. South Africa Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
8.5.1.8. South Africa Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
8.5.1.9. Egypt Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
8.5.1.10. Egypt Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
8.5.1.11. Egypt Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
8.5.1.12. Egypt Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
8.5.1.13. Nigeria Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
8.5.1.14. Nigeria Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
8.5.1.15. Nigeria Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
8.5.1.16. Nigeria Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Product, Value (US$ Bn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Mechanism, Value (US$ Bn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by Application Type, Value (US$ Bn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Oral Solid Dosage Contract Manufacturing Market by End User, Value (US$ Bn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Company Market Share Analysis, 2024
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Recipharm
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Aenova Holding
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Catalent
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. AbbVie
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Patheon N.V. (Thermo Fisher Scientific)
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. NextPharma
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Capsugel (Lonza Group AG)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Aurobindo Pharma Limited
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Siegfried AG
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Piramal Pharma Solutions
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Corden Pharma
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Kremoint Pharma Pvt Ltd.
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. HERMES PHARMA GmbH
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Medipaams India Private Limited
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. Alpex Pharma
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
9.4.16. Abaris Healthcare Pvt Ltd
9.4.16.1. Company Overview
9.4.16.2. Product Portfolio
9.4.16.3. Financial Overview
9.4.16.4. Business Strategies and Development
9.4.17. Ardena Holdings N.V
9.4.17.1. Company Overview
9.4.17.2. Product Portfolio
9.4.17.3. Financial Overview
9.4.17.4. Business Strategies and Development
9.4.18. Aphena Pharma Solutions
9.4.18.1. Company Overview
9.4.18.2. Product Portfolio
9.4.18.3. Financial Overview
9.4.18.4. Business Strategies and Development
9.4.19. Actiza Pharmaceutical Private Limited
9.4.19.1. Company Overview
9.4.19.2. Product Portfolio
9.4.19.3. Financial Overview
9.4.19.4. Business Strategies and Development
9.4.20. Sunwin Healthcare PVT. LTD
9.4.20.1. Company Overview
9.4.20.2. Product Portfolio
9.4.20.3. Financial Overview
9.4.20.4. Business Strategies and Development
9.4.21. Saffron Medicare PVT. LTD
9.4.21.1. Company Overview
9.4.21.2. Product Portfolio
9.4.21.3. Financial Overview
9.4.21.4. Business Strategies and Development
9.4.22. Dr Reddy’s Lab
9.4.22.1. Company Overview
9.4.22.2. Product Portfolio
9.4.22.3. Financial Overview
9.4.22.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Recipharm
  • Aenova Holding
  • Catalent
  • AbbVie
  • Patheon N.V. (Thermo Fisher Scientific)
  • NextPharma
  • Lonza Group AG
Merck KGaA
  • Aurobindo Pharma Limited
  • Siegfried AG
  • Piramal Pharma Solutions
  • Corden Pharma
  • HERMES PHARMA GmbH
  • Medipaams India Private Limited
  • Alpex Pharma
  • Abaris Healthcare Pvt Ltd
  • Ardena Holdings N.V
  • Aphena Pharma Solutions
  • Actiza Pharmaceutical Private Limited
  • Sunwin Healthcare PVT. LTD
  • Kosher Pharmaceuticals
  • Boehringer Ingelheim BioXcellence

Related Topics

Related Reports

High Potency API Contract Manufacturing Market by Product, by Synthesis, by Application, by Dosage Form, by End-User, and By Region - Product Image

High Potency API Contract Manufacturing Market by Product, by Synthesis, by Application, by Dosage Form, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2025-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing - Global Strategic Business Report - Product Image

Oral Solid Dosage Contract Manufacturing - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market Report 2025 - Product Image

Oral Solid Dosage Contract Manufacturing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.